Reported Earlier, Roivant Announced That Results From The Phase 2 Phocus Study Of Mosliciguat In Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-ild) Will Be Presented At The European Respiratory Society International Congress 2026 On Tuesday, September 8, 2026

뉴스 본문을 불러오고 있어요.

Reported Earlier, Roivant Announced That Results From The Phase 2 Phocus Study Of Mosliciguat In Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-ild) Will Be Presented At The European Respiratory Society International Congress 2026 On Tuesday, September 8, 2026 | 웨이프 WAPE

Reported Earlier, Roivant Announced That Results From The Phase 2 Phocus Study Of Mosliciguat In Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-ild) Will Be Presented At The European Respiratory Society International Congress 2026 On Tuesday, September 8, 2026

기사 요약

관련 종목

댓글 —